NMC
ORKA

NEA Management Company’s Oruka Therapeutics ORKA Stock Holding History

NEA Management Company’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,760
Closed -$1.97M – 44
2017
Q4 		$1.97M Hold
6,760
– – 0.08% 41
2017
Q3 		$1.68M Hold
6,760
– – 0.06% 40
2017
Q2 		$3.5M Hold
6,760
– – 0.13% 36
2017
Q1 		$3.72M Hold
6,760
– – 0.13% 32
2016
Q4 		$4.16M Hold
6,760
– – 0.17% 29
2016
Q3 		$4.13M Hold
6,760
– – 0.19% 29
2016
Q2 		$4.24M Hold
6,760
– – 0.22% 31
2016
Q1 		$5.07M Hold
6,760
– – 0.34% 28
2015
Q4 		$6.79M Hold
6,760
– – 0.43% 22
2015
Q3 		$7.24M Hold
6,760
– – 0.48% 25
2015
Q2 		$11.8M Buy
+6,760
New +$8.89M 0.61% 24

Other funds holding ORKA

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ACP
Aveo Capital Partners Englewood, Colorado $601M AUM 5.92% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

NEA Management Company's ORKA Position: Q1 2018 in Review

NEA Management Company sold out of Oruka Therapeutics (ORKA) in Q1 2018, closing a stake of 6,760 shares — an estimated $1.97M sold.

NEA Management Company first reported a position in ORKA in Q2 2015 and held it in 11 quarters. The position peaked at $11.8M in Q2 2015. 17 funds tracked by Wall St. Rank hold ORKA as of Q1 2018.

  • NEA Management Company reported no remaining Oruka Therapeutics position as of Q1 2018 after selling out during the quarter.
  • NEA Management Company sold 6,760 Oruka Therapeutics shares in Q1 2018, an estimated $1.97M.
  • NEA Management Company first reported a position in Oruka Therapeutics in Q2 2015 and held it in 11 quarters.
  • NEA Management Company's Oruka Therapeutics position peaked at $11.8M in Q2 2015.
  • 17 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2018.

Based on NEA Management Company's 13F filing for Q1 2018, filed 10 May 2018.